ANIX Anixa Biosciences Inc
Company Analysis
Latest News
🟢 Anixa Biosciences is trading 5.7% up today after Australian patent acceptance for breast cancer vaccine
Anixa Biosciences is trading at $3.70 (+5.71%) in pre-market following news of a patent acceptance in Australia for its breast cancer vaccine technology. •...
🟢 Anixa Biosciences is trading 10.7% up
Anixa Biosciences is trading at $3.53, up 10.7% from a comparison close of $3.19 during regular trading. This is a price-action follow-up, so a separate...
🟢 Anixa Biosciences is trading 6% up today after Australian patent acceptance for breast cancer vaccine
Anixa Biosciences is trading 5.6% up now at $3.37 after announcing Australian patent acceptance for its novel breast cancer vaccine platform. • The new patent...
Anixa Biosciences Secures Australian Patent for Aggressive Breast Cancer Vaccine
Anixa Biosciences received a notice of allowance from the Australian Patent Office for its novel breast cancer vaccine technology. The company is developing...
🟢 Anixa Biosciences is trading 5.6% up today on continued momentum from cancer therapy trials and a recent patent allowance
Anixa Biosciences is trading 5.6% up at $3.23 as investors focus on the company's ovarian cancer CAR-T/CER-T program and breast cancer vaccine developments. •...
🟢 Anixa Biosciences is trading 6.6% up today as it rebounds from a recent pullback amid trial momentum
Anixa Biosciences is trading at $3.26 (up 6.6%) in pre-market, rebounding from a 4.97% pullback to $3.06 on July 10. • The upward move follows continued...
🔴 Anixa Biosciences is trading 6.8% down today in a likely pullback after recent gains
Anixa Biosciences is trading 6.8% down at $3.00 in a likely pullback following several strong sessions earlier this week. • No new company-specific news or...
🟢 Anixa Biosciences is trading 5.47% up today as momentum continues
Anixa Biosciences is trading at $3.28 (+5.47%) in pre-market as it extends recent momentum following a strong session on July 8. • The move appears to be a...
🟢 ANIX extends move to 5.9% up
ANIX is trading at $3.13, up 5.9% versus the comparison close of $2.96 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ANIX is trading 5% up today after treating first patient in fifth cohort of CAR-T trial
ANIX is trading at $3.11 (+5.06%) today after treating the first patient in the highest-dose fifth cohort of its Phase 1 ovarian cancer CAR-T trial. • No...
🟢 ANIX is trading 9.5% up today after ovarian cancer CAR-T trial milestone
ANIX is trading 9.5% up today at $3.24 as investors refocus on progress within its ovarian cancer CAR-T program. • The company recently treated the first...
Anixa's Ovarian Cancer Therapy Hits Its Highest Dose Yet — But Can a $110 Million Biotech Sustain the Momentum?
Shares of Anixa Biosciences surged 12.5% to $3.33 after hours on July 8, reversing a classic "sell the news" dip that dragged the stock from $3.27 to $2.96 in...
🟢 ANIX is trading 12.5% up today following positive ovarian cancer CAR-T trial data
ANIX is trading at $3.33 (12.5% up) in after-hours trading following positive clinical updates from its ovarian cancer CAR-T trial. • The trial successfully...
🔴 ANIX is trading 5.6% down today on a sell the news reaction to its ovarian cancer CAR-T trial update
ANIX is trading at $2.88 (-5.57%) following a sell the news reaction to its latest ovarian cancer CAR-T trial update. • The company reported that the trial...
🔴 ANIX Dips 6.9% in Pre-Market, Despite Positive Ovarian Cancer CAR-T Trial Update
• Anixa Biosciences announced on July 6th that its ovarian cancer CAR-T clinical trial advanced to its highest dose level to date, with no dose-limiting...